Clinical Trial Update: A Study to Assess the Safety of a New Inserter Device for Paragard® (Intrauterine Copper Contraceptive) [Phase 4]

View source ↗

Summary

Phase 4 trial updating safety of a new inserter device for Paragard intrauterine copper contraceptive completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception

Drugs mentioned

• ParaGard (copper intrauterine device)

Snippet

Sponsor: CooperSurgical Inc. | Conditions: Contraception | Phase 4 | Status: COMPLETED